Trending

Alector

Alector kicks off biotech IPOs after US government shutdown

Alector kicks off biotech IPOs after US government shutdown

The 35-day US government shutdown has not just played havoc at government-run agencies – it has had a

X

Alector kicks off biotech IPOs after US government shutdown

https://pharmaphorum.com/news/alector-kicks-off-biotech-ipos-after-us-government-shutdown/

AbbVie signs $225m ‘immunoneurology’ deal to tackle Alzheimer’s

AbbVie signs $225m ‘immunoneurology’ deal to tackle Alzheimer’s

Partnership will use novel approach to treating Alzheimer’s.

X

AbbVie signs $225m ‘immunoneurology’ deal to tackle Alzheimer’s

https://pharmaphorum.com/news/abbvie-immunoneurology-alzheimers/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com